Cargando…

An orally effective dihydropyrimidone (DHPM) analogue induces apoptosis-like cell death in clinical isolates of Leishmania donovani overexpressing pteridine reductase 1

The protozoan parasite Leishmania donovani is the causative agent of visceral leishmaniasis. The enzyme pteridine reductase 1 (PTR1) of L. donovani acts as a metabolic bypass for drugs targeting dihydrofolate reductase (DHFR); therefore, for successful antifolate chemotherapy to be developed against...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Neeloo, Kaur, Jaspreet, Kumar, Pranav, Gupta, Swati, Singh, Nasib, Ghosal, Angana, Dutta, Avijit, Kumar, Ashutosh, Tripathi, RamaPati, Siddiqi, Mohammad Imran, Mandal, Chitra, Dube, Anuradha
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2009
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745541/ https://www.ncbi.nlm.nih.gov/pubmed/19621245 http://dx.doi.org/10.1007/s00436-009-1557-z

Ejemplares similares

Bioinformatic Analysis of Leishmania donovani Long-Chain Fatty Acid-CoA Ligase as a Novel Drug Target
por: Kaur, Jaspreet, et al.
Publicado: (2011)

Structure of recombinant Leishmania donovani pteridine reductase reveals a disordered active site
por: Barrack, Keri L., et al.
Publicado: (2010)

Dihydropyrimidone Derivatives as Thymidine Phosphorylase Inhibitors: Inhibition Kinetics, Cytotoxicity, and Molecular Docking
por: Cui, Tian-Meng, et al.
Publicado: (2023)

SOLiD™ Sequencing of Genomes of Clinical Isolates of Leishmania donovani from India Confirm Leptomonas Co-Infection and Raise Some Key Questions
por: Singh, Neeloo, et al.
Publicado: (2013)

Evaluation of Leishmania donovani Protein Disulfide Isomerase as a Potential Immunogenic Protein/Vaccine Candidate against Visceral Leishmaniasis
por: Kushawaha, Pramod Kumar, et al.
Publicado: (2012)

Characterization of Glycolytic Enzymes - rAldolase and rEnolase of Leishmania donovani, Identified as Th1 Stimulatory Proteins, for Their Immunogenicity and Immunoprophylactic Efficacies against Experimental Visceral Leishmaniasis
por: Gupta, Reema, et al.
Publicado: (2014)

Leishmania donovani Triose Phosphate Isomerase: A Potential Vaccine Target against Visceral Leishmaniasis
por: Kushawaha, Pramod K., et al.
Publicado: (2012)

Evolutionary comparison of prenylation pathway in kinetoplastid Leishmania and its sister Leptomonas
por: Chauhan, Indira Singh, et al.
Publicado: (2015)

Over-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovani
por: Das, Sanchita, et al.
Publicado: (2015)

Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani
por: Joshi, Sumit, et al.
Publicado: (2019)

Cloning, Expression and Purification of L. Donovani Specific Antigen for Serodiagnosis of Visceral Leishmaniasis
por: Kumar, Dinesh, et al.
Publicado: (2013)

Identification of Kaurane-Type Diterpenes as Inhibitors of Leishmania Pteridine Reductase I
por: Herrera-Acevedo, Chonny, et al.
Publicado: (2021)

Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases
por: Santucci, Matteo, et al.
Publicado: (2021)

Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis
por: Baharia, Rajendra K, et al.
Publicado: (2015)

Identification and Characterization of a Novel Palmitoyl Acyltransferase as a Druggable Rheostat of Dynamic Palmitoylome in L. donovani
por: Ayana, R., et al.
Publicado: (2018)

Combined gene deletion of dihydrofolate reductase-thymidylate synthase and pteridine reductase in Leishmania infantum
por: Bhattacharya, Arijit, et al.
Publicado: (2021)

A member of the Ras oncogene family, RAP1A, mediates antileishmanial activity of monastrol
por: Kaur, Jaspreet, et al.
Publicado: (2013)

Correction: Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis
por: Baharia, Rajendra K, et al.
Publicado: (2015)

Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate
por: Dawson, Alice, et al.
Publicado: (2006)

Dissecting the Metabolic Roles of Pteridine Reductase 1 in Trypanosoma brucei and Leishmania major
por: Ong, Han B., et al.
Publicado: (2011)

Trypanosoma brucei pteridine reductase 1 is essential for survival in vitro and for virulence in mice
por: Sienkiewicz, Natasha, et al.
Publicado: (2010)

Structure-Based Design and Synthesis of Antiparasitic Pyrrolopyrimidines Targeting Pteridine Reductase 1
por: Khalaf, Abedawn I., et al.
Publicado: (2014)

Development and validation of a cytochrome c-coupled assay for pteridine reductase 1 and dihydrofolate reductase
por: Shanks, Emma J., et al.
Publicado: (2010)

Evidence of Pyrimethamine and Cycloguanil Analogues as Dual Inhibitors of Trypanosoma brucei Pteridine Reductase and Dihydrofolate Reductase
por: Tassone, Giusy, et al.
Publicado: (2021)

Structure-Based Design of Pteridine Reductase Inhibitors Targeting African Sleeping Sickness and the Leishmaniases
por: Tulloch, Lindsay B., et al.
Publicado: (2009)

Design, Synthesis and Biological Evaluation of Novel Inhibitors of Trypanosoma brucei Pteridine Reductase 1
por: Spinks, Daniel, et al.
Publicado: (2011)

In Silico Identification and In Vitro Evaluation of Natural Inhibitors of Leishmania major Pteridine Reductase I
por: Herrmann, Fabian C., et al.
Publicado: (2017)

Leishmania donovani Internalizes into Host Cells via Caveolin-mediated Endocytosis
por: Kumar, G. Aditya, et al.
Publicado: (2019)

Sesquiterpene Lactones with Dual Inhibitory Activity against the Trypanosoma brucei Pteridine Reductase 1 and Dihydrofolate Reductase
por: Possart, Katharina, et al.
Publicado: (2021)

Quantitative Proteome Analysis of Leishmania donovani under Spermidine Starvation
por: Singh, Shalini, et al.
Publicado: (2016)

Over-Expression of 60s Ribosomal L23a Is Associated with Cellular Proliferation in SAG Resistant Clinical Isolates of Leishmania donovani
por: Das, Sanchita, et al.
Publicado: (2013)

Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity
por: Di Pisa, Flavio, et al.
Publicado: (2017)

Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1
por: Pöhner, Ina, et al.
Publicado: (2022)

Structure and dynamics of pteridine reductase 1: the key phenomena relevant to enzyme function and drug design
por: Panecka-Hofman, Joanna, et al.
Publicado: (2023)

Characterization of Leishmania donovani MCM4: Expression Patterns and Interaction with PCNA
por: Minocha, Neha, et al.
Publicado: (2011)

In Silico and In Vitro Search for Dual Inhibitors of the Trypanosoma brucei and Leishmania major Pteridine Reductase 1 and Dihydrofolate Reductase
por: Possart, Katharina, et al.
Publicado: (2023)

Comparison of Pteridine Normalization Methods in Urine for Detection of Bladder Cancer
por: Kośliński, Piotr, et al.
Publicado: (2020)

1H-Benzo[g]pteridine-2,4-dione
por: Uppu, Rao M., et al.
Publicado: (2023)

Urinary pteridines as a discriminator of atherosclerotic risk in patients with diabetes
por: Marumo, Mikio, et al.
Publicado: (2021)

Deprivation of L-Arginine Induces Oxidative Stress Mediated Apoptosis in Leishmania donovani Promastigotes: Contribution of the Polyamine Pathway
por: Mandal, Abhishek, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m0aqc6nrl60e1254u7tav7gfjc